S100A12: a noninvasive marker of inflammation in inflammatory bowel disease. - Wikidata - awgldk - TriplyDB

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

http://www.wikidata.org/entity/Q38059248

about

Emerging role of novel biomarkers in the diagnosis of inflammatory bowel disease Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives Biomarkers of inflammatory bowel disease.The Human Antimicrobial Protein Calgranulin C Participates in Control of Helicobacter pylori Growth and Regulation of Virulence.Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine Serum levels of S100A6 are unaltered in patients with resectable cholangiocarcinoma.Serum omentin-1 as a disease activity marker for Crohn's disease.Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.Emerging Biomarkers for the Diagnosis and Monitoring of Inflammatory Bowel Diseases.Noninvasive Markers of Disease Activity in Inflammatory Bowel Disease.Associations between Soluble Receptor for Advanced Glycation End Products (sRAGE) and S100A12 (EN-RAGE) with Mortality in Long-term Hemodialysis Patients.S100A12 expression in patients with primary biliary cirrhosis.S100A12 as a marker of worse cardiac output and mortality in pulmonary hypertension.Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.

P2860

Q26768273-8990921D-78C9-469C-925A-3380AA5A093B Q27027429-BB44BF9C-1395-463C-9637-380B1B2B2688 Q28085134-582460F7-0022-4FFE-8955-A8DF3DD9E2B8 Q33746983-CDB37285-293D-493E-ACE7-81DB06A601A8 Q35745580-8FF61122-E359-444E-891E-D77F7EB87275 Q36052700-A7C0AE8E-7008-4213-AEA0-E8D08353111A Q37314018-2F1A1E54-43BD-438F-A4AD-2506A7916E6C Q37603086-E9F275B3-5CB0-47BE-B470-3DA87F5813B4 Q38376238-8A1B42B0-2504-4C9F-BB93-5AA9AC178491 Q38896550-1059645A-B661-4EF6-A26D-29DB9CBD968A Q39464033-B3A76B20-09F0-47E4-B627-E6BBE037EEE2 Q40443709-32B0096C-DDE0-4D99-A66C-9DA70BFC61AB Q41702160-489FE2C6-7158-40AC-9DFC-A8BC9CCB64C1 Q52610998-CA4FF291-ED1F-42A9-BBAF-BE0B7D0A551B Q52668734-85E3A08C-24CA-4689-8C77-FA13E4BD7652

P2860

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

http://www.wikidata.org/entity/Q38059248

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

@en

type

label

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

@en

prefLabel

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

@en

P1433

Q38059248-91E28A17-7BBE-4890-BFB1-B8FB16692D99

P1476

Q38059248-C7EE0231-A205-4F6E-AC40-68B43EA67B75

P2093

Q38059248-564F36DC-927D-4B70-8221-8D327E9E0DB0

Q38059248-B9F9438A-5F30-43CB-B87C-72C095399B94

P2860

Q38059248-11132171-0EE5-4000-BF5C-2434076A51C5

Q38059248-396DAFC7-A310-4A36-B00C-C9D767994138

Q38059248-3B136BF0-4988-4C28-9310-44903F526376

Q38059248-3B2C165E-DEC3-4CBE-89F0-402C09DE26EE

Q38059248-4084D218-5C3D-4B18-A4BD-92DAC66CE2F3

Q38059248-51BAE7E4-6590-491C-8D5E-1552DC30CB19

Q38059248-5558867C-7637-4156-B30B-5D2379745C29

Q38059248-79DB80A7-B445-495E-8721-D6C8ECF8E5EA

Q38059248-8FFA5A61-3921-4967-903D-05AF73CC5211

Q38059248-95515107-15ED-4DDA-ABBE-2FA07B48849D

P304

Q38059248-F8551D3D-D740-42A2-BB1F-E7FA0D18BC4F

P31

Q38059248-5575E5A1-DE87-4F5E-9FE9-BDD57BF03D5C

P356

Q38059248-9C6BF109-62DE-4259-9910-CD0F66E12F44

P433

Q38059248-7BC50320-EDAC-4B19-912D-133BB0868302

P478

Q38059248-F81A5BF9-D345-40CA-934D-F4142DD2DBAE

P577

Q38059248-B5D380F8-CDBB-484B-A59B-9A2DB9436B84

P698

Q38059248-BCB0B6D0-113E-4E24-9AF5-4FDD8E000D6F

P921

Q38059248-A1C3B240-8637-4E13-BBB0-F17567E29879

Q38059248-D087293E-46AA-483A-B38C-7EE4B1AB42D4

P356

1751-2980.12012

P1433

Journal of Digestive Diseases

P1476

S100A12: a noninvasive marker of inflammation in inflammatory bowel disease.

@en

P2093

Andrew S Day

http://www.w3.org/2001/XMLSchema#string

Floor van de Logt

http://www.w3.org/2001/XMLSchema#string

P2860

RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides

Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

Intracellular and extracellular roles of S100 proteins

Characterization of the human S100A12 (calgranulin C, p6, CAAF1, CGRP) gene, a new member of the S100 gene cluster on chromosome 1q21

Moderate performance of serum S100A12, in distinguishing inflammatory bowel disease from irritable bowel syndrome

Faecal alpha-1-antitrypsin and excretion of 111indium granulocytes in assessment of disease activity in chronic inflammatory bowel diseases

Laboratory values for children with newly diagnosed inflammatory bowel disease.

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome.

High incidence of Crohn's disease in Canterbury, New Zealand: results of an epidemiologic study.

Review article: biological activity markers in inflammatory bowel disease.

P304

62-67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/1751-2980.12012

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23146044

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases